USTEKINUMAB
ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial
USTEKINUMAB (12664M)
12664M
Manner of administration:Injection
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: First continuing treatment (Whole body) - treatment covering week 28 and onwards
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: First continuing treatment (Face, hand, foot) - treatment covering week 28 and onwards
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment (Whole body)
Restriction
Indication: Severe chronic plaque psoriasis
Treatment phase: Subsequent continuing treatment (Face, hand, foot)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $789.74 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Stelara | |||||